The Food and Drug Administration (FDA) yesterday announced a recall of 10,000 doses of the antibiotic Targocid, a drug used to treat infective endocarditis.
Hung Kuo-teng (洪國登), the head of the FDA’s Medicinal Products Division, said Targocid 400mg for Injection, produced in batch 1J5721 by French multinational pharmaceutical company Sanofi, is the target of the recall.
The FDA said that about 10,000 doses from that batch has been distributed throughout Taiwan. All doses identified should be returned by March 6.
Photo: AFP
Clinics, hospitals and pharmacies have been asked to stop prescribing the drug and contact anyone known to have been prescribed the drug, Hung said.
Sanofi voluntarily notified the FDA in October last year that problems might have arisen on the drug’s production line, he said.
The FDA asked the company for more information, and was told that the batch in question was slightly contaminated with a water soluble corticosteroid known as methylprednisolone hemisuccinate.
The corticosteroid is used to relieve a number of ailments such as severe allergic reactions, respiratory diseases and nervous system conditions.
About 120,000 doses of Targocid are prescribed annually under Taiwan’s national health insurance program, accounting for 80 percent of the market for drugs of the same nature made with the same active ingredients and dosage, Hung said.
However, patients who rely on the medication should not be concerned that a recall might cause a shortage of the drug, as Taiwan has enough other brands offering the same active ingredient, he said.
The FDA recommended that people concerned about the issue should visit a doctor to discuss alternative medications.
Targocid’s primary application is for the treatment of infective endocarditis caused by staphylococcus.
Secondary applications include the treatment of osteomyelitis, pneumonia, sepsis, soft tissue infection and small intestine inflammation.
FUKUOKA SITUATION: Japanese media reported that the pathogen is expected to be identified by the summer, while the CDC downplayed the idea that it was hMPV A “mysterious cold-like illness” reported in Japan’s Fukuoka Prefecture does not seem to be a new disease, but Japanese authorities have been asked about the situation, the Centers for Disease Control (CDC) said yesterday. The Fukuoka Prefectural Medical Association on Wednesday told a news conference that a “mystery cold” that has become a hot topic on social media is “highly likely to be caused by some kind of viral infection,” Japan’s KBC News reported. “Many people are experiencing symptoms starting with a sore throat, followed by a runny nose, phlegm and a severe cough,” KBC News reported, citing association officials. Health authorities are
Nvidia Corp CEO Jensen Huang (黃仁勳) arrived in Taiwan yesterday ahead of upcoming AI and technology events, saying he plans to meet with clients and Taiwan Semiconductor Manufacturing Co Chairman C.C. Wei (魏哲家) during his visit. After landing at Taipei Songshan Airport, Huang posed for photos with fans and handed out Yakult drinks to reporters and supporters waiting at the scene, saying he has “a lot to do” during the trip. Asked about reports that Nvidia’s planned headquarters site in Taipei’s Beitou Shilin Technology Park could break ground on May 27, Huang said that if the company holds an event, he would
The Ministry of Finance this afternoon announced the winning numbers for the March-April uniform invoice lottery. The winning number for the NT$10 million (US$318,060) special prize is 19531471, and the winning number for the NT$2 million grand prize is 85941329. Three numbers were drawn for the NT$200,000 first prize: 07225810, 20231230 and 83518781. Those with receipts matching the last seven digits of any of the first-prize numbers will win the NT$40,000 second prize, while those matching the last six digits will win the NT$10,000 third prize. Those whose receipts match the last five digits of the first-prize numbers can claim the NT$4,000 fourth prize,
Taiwan Travelogue (臺灣漫遊錄), which earlier this week became the first Taiwanese novel to win the International Booker Prize, is to be adapted into a television series through a Taiwan-Japan coproduction, producer Chang Chen-yu (張辰漁) said yesterday. Chang, a producer at World Softest Production Film Co, wrote on Facebook that the company had been searching for projects with international appeal that retain a strong Taiwanese identity after colleagues and Japanese partners strongly recommended the novel. After reading the book, Chang said he immediately decided to pursue the screen rights. “A great story has the power to transcend time and borders, and connect countless people,”
RSS